[CLDX] YoY Quarter Result on 30-Jun-2012 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
09-Aug-2012
Financial Year
2012
Quarter
30-Jun-2012 [#Q2]
Profit Trend
QoQ- -1.90%
YoY- -34.55%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 2,178 592 97 2,009 1,952 2,951 2,685 -3.42%
PBT -32,359 -28,274 -19,016 -13,362 -9,802 -9,191 -8,705 24.44%
Tax -782 -275 -161 -252 -158 -190 -36 66.99%
NP -32,359 -28,274 -19,016 -13,773 -10,236 -9,525 -8,705 24.44%
Tax Rate - - - - - - - -
Total Cost 34,537 28,866 19,113 15,782 12,188 12,476 11,390 20.29%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin -1,485.72 -4,776.01 -19,604.12 -685.56 -524.39 -322.77 -324.21 28.86%
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
EPS -4.93 -4.75 -3.53 -3.52 -4.10 -4.49 -8.25 -8.21%
EPS Diluted -4.93 -4.75 -3.53 -3.52 -4.10 -4.49 -8.25 -8.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.